CVE-2016-0291

CVE-2016-0291 is a high-severity vulnerability in Ibm Bigfix Platform with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

IBM BigFix Platform 9.0, 9.1 before 9.1.8, and 9.2 before 9.2.8 allow remote authenticated users to execute arbitrary commands by leveraging report server access. IBM X-Force ID: 111302.

Frequently asked questions

What is CVE-2016-0291?
IBM BigFix Platform 9.0, 9.1 before 9.1.8, and 9.2 before 9.2.8 allow remote authenticated users to execute arbitrary commands by leveraging report server access. IBM X-Force ID: 111302.
How severe is CVE-2016-0291?
CVE-2016-0291 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2016-0291 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 4% (89th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2016-0291?
CVE-2016-0291 primarily affects Ibm Bigfix Platform. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2016-0291?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2016-0291 published?
CVE-2016-0291 was published on 2018-02-28 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Ibm Bigfix Platform

All CVEs affecting Ibm Bigfix Platform →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →